Insider Trading & Ownership - Posard Matthew L.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Posard Matthew L.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-12-02
Sale
2022-12-06
7:07 pm
HALOZYME THERAPEUTICS INC.HALOPosard Matthew L.
Director
30,000$56.88$1,706,550105,189
(Direct)
View
2021-11-30
Purchase
2021-12-01
9:41 pm
Nautilus Biotechnology Inc.NAUTPosard Matthew L.
Director
50,000$4.5101$225,505150,000
(Indirect
Direct)
View
2021-02-17
Purchase
2021-02-19
6:13 pm
Talis Biomedical CorpTLISPosard Matthew L.
Director
62,500$16$1,000,00062,500
(Direct)
View
2021-01-11
Purchase
2021-01-13
4:21 pm
DermTech Inc.DMTKPosard Matthew L.
Director
33,898$29.5$999,99186,863
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-06-15
Option Award
2023-06-16
7:52 pm
N/A
2033-06-15
Nautilus Biotechnology Inc.NAUTPosard Matthew L.
Director
45,000$045,000
(Direct)
View
2023-06-09
Option Award
2023-06-12
5:28 pm
N/A
2033-06-09
Talis Biomedical CorpTLISPosard Matthew L.
Director
95,000$095,000
(Direct)
View
2023-06-01
Option Award
2023-06-05
6:20 pm
N/A
N/A
DermTech Inc.DMTKPosard Matthew L.
Director
35,714$0158,215
(Direct)
View
2023-05-05
Option Award
2023-05-09
6:27 pm
2024-05-05
2033-05-05
HALOZYME THERAPEUTICS INC.HALOPosard Matthew L.
Director
19,436$0124,625
(Direct)
View
2022-06-15
Option Award
2022-06-16
8:04 pm
N/A
2032-06-15
Nautilus Biotechnology Inc.NAUTPosard Matthew L.
Director
86,467$086,467
(Direct)
View
2022-06-10
Option Award
2022-06-13
5:41 pm
N/A
2032-06-09
Talis Biomedical CorpTLISPosard Matthew L.
Director
95,000$095,000
(Direct)
View
2022-05-26
Option Award
2022-05-31
8:11 pm
N/A
N/A
DermTech Inc.DMTKPosard Matthew L.
Director
26,480$0122,501
(Direct)
View
2022-05-05
Option Award
2022-05-06
8:07 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOPosard Matthew L.
Director
6,206$0135,189
(Direct)
View

Ownership
2021-06-09
9:38 pm
N/A
N/A
Nautilus Biotechnology Inc.NAUTPosard Matthew L.
Director
0$0368,476
(Indirect)
View
2021-05-26
Option Award
2021-05-28
8:19 pm
N/A
N/A
DermTech Inc.DMTKPosard Matthew L.
Director
9,158$096,021
(Direct)
View
2021-05-05
Option Award
2021-05-06
8:04 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOPosard Matthew L.
Director
5,230$0128,983
(Direct)
View

Ownership
2021-02-11
7:13 pm
N/A
2030-02-11
Talis Biomedical CorpTLISPosard Matthew L.
Director
0$0143,779
(Direct)
View
2020-06-17
Option Award
2020-06-19
4:19 pm
N/A
N/A
DermTech Inc.DMTKPosard Matthew L.
Director
8,000$052,965
(Direct)
View
2020-04-30
Option Award
2020-05-01
7:15 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOPosard Matthew L.
Director
8,829$0123,753
(Direct)
View
2020-04-29
Exercise
2020-05-01
4:24 pm
N/A
2026-09-21
DermTech Inc.DMTKPosard Matthew L.
Director
9,702$044,965
(Direct)
View
2020-04-29
Exercise
2020-05-01
4:24 pm
N/A
N/A
DermTech Inc.DMTKPosard Matthew L.
Director
9,702$6.9444,965
(Direct)
View
2020-01-30
Option Award
2020-02-03
4:15 pm
N/A
N/A
DermTech Inc.DMTKPosard Matthew L.
Director
6,000$035,263
(Direct)
View
2019-12-31
Exercise
2020-01-03
4:10 pm
N/A
N/A
DermTech Inc.DMTKPosard Matthew L.
Director
15,994$029,263
(Direct)
View

Ownership
2019-09-09
8:21 pm
N/A
N/A
DermTech Inc.DMTKPosard Matthew L.
Director
0$038,965
(Direct)
View
2019-05-02
Option Award
2019-05-03
4:23 pm
N/A
N/A
HALOZYME THERAPEUTICS INCHALOPosard Matthew L.
Director
12,173$0114,924
(Direct)
View